VSNT
RCL
MKC
CCZ
ATR

Maritza Gomez Montiel

Known title: DirectorCIK: 0001640081

Maritza Gomez Montiel's purchase track record

Maritza Gomez Montiel has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/10/2023RCL$104K-10.6%+16.8%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Morgan Stanley initiates VSNT coverage with Equal-Weight rating. Morgan Stanley has started covering Versant Media Group, assigning it an Equal-Weight rating and a $38 price target. This new analyst coverage provides a fresh perspective on the stock, which currently trades near its support level. The move adds to the existing analyst consensus, where the average target price stands at $44.57.

this person other insiders at VSNT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Royal Caribbean Stock Rises 12% as Earnings Outlook Improves. Recent news highlights Royal Caribbean's 12% stock rise over the past month, outperforming the broader market. The company faces questions regarding its expanded Europe lineup and whether it can continue to beat earnings estimates. Industry observers suggest the cruise sector may see calmer waters in upcoming quarters, supporting the recent stock momentum.

this person other insiders at RCL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

McCormick Analysts Lower Targets After Q3 Results. McCormick shares have come under pressure as several analysts, including UBS and TD Cowen, lowered their price targets following third-quarter results. While BNP Paribas maintained a positive outlook, the broader trend reflects reduced expectations for near-term growth. The company has also replaced its auditor with KPMG and reaffirmed its overall financial outlook despite the recent stock decline.

this person other insiders at MKC
this person other insiders at CCZ

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

AptarGroup Secures CE Marking for LuerVax as UBS Starts Coverage. AptarGroup announced that its LuerVax product and accompanying spray divider have received CE marking, a regulatory step that supports vaccine developers. Separately, UBS initiated coverage on the stock with a neutral rating and a price target of $135. The company's average analyst target remains $162.00, with a range extending to $220.00.

this person other insiders at ATR

Transaction History

VSNT▲ Buy$185K
RCL▼ Sell$22K
RCL▲ Buy$0
RCL▼ Sell$453K
MKC▲ Buy—
VSNT▲ Buy—
RCL▼ Sell$310K
RCL▲ Buy$0
RCL▼ Sell$364K
MKC▲ Buy$313K
MKC▼ Sell$489K
MKC▲ Buy$0
MKC▲ Buy$150K
MKC▲ Buy$334K
MKC▼ Sell$524K
MKC▼ Sell$231K
CCZ▲ Buy$0
MKC▲ Buy$350K
MKC▼ Sell$539K
MKC▲ Buy$0
RCL▲ Buy$0
CCZ▼ Sell$2K
CCZ▲ Buy$0
RCL▲ Buy$104K
ATR▲ Buy$0
MKC▲ Buy—
ATR▼ Sell$172K
RCL▲ Buy$0
CCZ▲ Buy$0
CCZ▼ Sell$34
CCZ▲ Buy$0
CCZ▲ Buy$0
CCZ▲ Buy$0
ATR▲ Buy$0
CCZ▲ Buy$0
MKC▲ Buy—
ATR▼ Sell$129K
RCL▲ Buy$0
CCZ▲ Buy$0
CCZ▲ Buy$0
CCZ▼ Sell$773
MKC▼ Sell$32K
MKC▼ Sell$251K
MKC▲ Buy$118K
MKC▼ Sell$241K
CCZ▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.